NIH-funded research NIH-funded research

Support for clinical trial design and data management

Official title: Research Design, Compliance, and Data Management (RDCD)

Funded at University of Louisville · NIH-10983876 · Data updated 2026-11-12

This study is all about helping researchers who are working on cancer treatments by making it easier for them to use health records and analyze their data, so they can improve the quality of their studies and ultimately help patients like you.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Louisville
NIH-funded
Lab location1 site (Louisville, United States)
Project startJuly 10, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$252,707
NIH project number1P20GM155899-01
Project IDNIH-10983876 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals involved in or affected by ongoing clinical trials at the University of Louisville.

Less likely to help

Patients not participating in clinical trials or those outside the geographic area of Louisville may not receive direct benefits from this research.

What this research studies

This research focuses on providing essential support to investigators conducting clinical trials by offering statistical assistance for experimental design and data analysis. It aims to improve access to Electronic Health Records (EHR) databases, facilitating the conduct of cancer and translational research. The team, led by Dr. Maiying Kong, collaborates closely with various experts to ensure compliance with federal regulations and enhance the quality of clinical research. By creating robust research databases and providing guidance on risk management, this initiative seeks to streamline the research process for better patient outcomes.

Why it matters

Potential benefit: If successful, this research could enhance the efficiency and effectiveness of clinical trials, leading to improved treatment options for patients.

How similar studies have gone: Similar research initiatives have shown success in improving clinical trial processes and patient outcomes, indicating a promising approach.

Where this research is happening

  • University of Louisville
    Louisville, United States
    Active

Researchers

  • Principal investigator: Kong, Maiying — University of Louisville
  • Study coordinator: Kong, Maiying

Related research

Other NIH-funded projects on the same topics.

  • Gastric rhythm map to understand stomach problems using a new noninvasive tool

    A new noninvasive body surface mapping method is being tested to see if abnormal stomach electrical rhythms explain chronic stomach problems like functional dyspepsia and persistent nausea.

    NIH research University of Louisville · Louisville, United States · NIH-11611507

  • Novel antivirals for alphavirus arthritis

    A research team is refining a promising antiviral compound to treat alphavirus infections that cause arthritis, with a focus on Chikungunya and related viruses.

    NIH research University of Louisville · Louisville, United States · NIH-11609180

  • Linking heavy metal exposure to a tougher breast cancer type (TNBC)

    Aimed at understanding how heavy metals like cadmium might trigger a dangerous breast cancer type (TNBC) in people, especially those with BRCA1 risk, to identify possible future treatment strategies.

    NIH research University of Louisville · Louisville, United States · NIH-11567535

  • Cardiac safety of flavored e-cigarette aerosols in adults

    A pharmacist or clinician would test how inhaling flavored e-cigarette aerosols affects heart rhythm in adults to see if flavors raise the risk of heart problems.

    NIH research University of Louisville · Louisville, United States · NIH-11541950

  • Biomedical Research Facilities to Expand Precision Medicine in Kentucky

    A large NIH grant aims to renovate and expand a shared precision medicine center in Kentucky to speed up research that could improve health for people in Appalachia and surrounding areas.

    NIH research University of Louisville · Louisville, United States · NIH-11523167

  • Rac-enhanced CAR-Macrophages against TNBC

    A new cell therapy approach uses engineered macrophages with a CAR and Rac2 activation to target and kill triple-negative breast cancer cells expressing CSPG4.

    NIH research University of Louisville · Louisville, United States · NIH-11520503

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.